The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
127886291 12788629 1 I 20160919 20160928 20160928 EXP US-BAXTER-2016BAX050238 BAXTER BENSIMHON P, VILLABLANCA J, SENDER L, MATTAHAY K, PARK J, SEEGER R, LONDON W, YAP J, KREISSMAN S. PERIPHERAL BLOOD STEM CELL SUPPORT FOR MULTIPLE CYCLES OF DOSE INTENSIVE INDUCTION THERAPY IS FEASIBLE WITH LITTLE RISK OF TUMOR CONTAMINATION IN ADVANCED STAGE NEUROBLASTOMA: A REPORT FROM THE CHILDRENS ONCOLOGY GROUP. PEDIATRIC BLOOD AND CANCER. 2010 JAN 01;54(4):596-602. 60.00 MON F Y 17.20000 KG 20160928 MD US US

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
127886291 12788629 1 PS CYCLOPHOSPHAMIDE FOR INJECTION, USP CYCLOPHOSPHAMIDE 1 Unknown 2 GM/M2/DAY, DAY 0 AND 1 FOR 2 CYCLES U 40745 POWDER FOR SOLUTION FOR INJECTION
127886291 12788629 2 SS CYCLOPHOSPHAMIDE FOR INJECTION, USP CYCLOPHOSPHAMIDE 1 Intravenous (not otherwise specified) 2 G/M2/DAY, DAY 0 AND 1 FOR 3 CYCLES U 40745 POWDER FOR SOLUTION FOR INJECTION
127886291 12788629 3 SS MESNEX MESNA 1 Unknown ON DAYS 1 AND 2 U 20855 FILM-COATED TABLET
127886291 12788629 4 SS VINCRISTINE VINCRISTINE 1 Intravenous drip DAY 0 AND 1 FOR TWO CYCLES U 0
127886291 12788629 5 SS DOXORUBICIN DOXORUBICIN 1 Unknown DAY 0 AND 1 FOR TWO CYCLES U 0
127886291 12788629 6 SS G-CSF GRANULOCYTE COLONY-STIMULATING FACTOR NOS 1 Unknown U 0
127886291 12788629 7 SS G-CSF GRANULOCYTE COLONY-STIMULATING FACTOR NOS 1 Unknown U 0
127886291 12788629 8 SS G-CSF GRANULOCYTE COLONY-STIMULATING FACTOR NOS 1 Unknown U 0
127886291 12788629 9 SS G-CSF GRANULOCYTE COLONY-STIMULATING FACTOR NOS 1 Unknown U 0
127886291 12788629 10 SS G-CSF GRANULOCYTE COLONY-STIMULATING FACTOR NOS 1 Unknown U 0
127886291 12788629 11 SS G-CSF GRANULOCYTE COLONY-STIMULATING FACTOR NOS 1 Unknown U 0
127886291 12788629 12 SS G-CSF GRANULOCYTE COLONY-STIMULATING FACTOR NOS 1 Unknown U 0
127886291 12788629 13 SS G-CSF GRANULOCYTE COLONY-STIMULATING FACTOR NOS 1 Unknown U 0
127886291 12788629 14 SS CARBOPLATIN. CARBOPLATIN 1 Intravenous (not otherwise specified) DAY 0 AND 1 FOR THREE CYCLES U 0 1000 MG/M**2
127886291 12788629 15 SS ETOPOSIDE. ETOPOSIDE 1 Intravenous (not otherwise specified) ON DAY 0, 1 AND 2 FOR 3 CYCLES U 0

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
127886291 12788629 1 Neuroblastoma
127886291 12788629 3 Neuroblastoma
127886291 12788629 4 Neuroblastoma
127886291 12788629 5 Neuroblastoma
127886291 12788629 6 Product used for unknown indication
127886291 12788629 14 Neuroblastoma
127886291 12788629 15 Neuroblastoma

Outcome of event

Event ID CASEID OUTC COD
127886291 12788629 OT

Reactions reported

Event ID CASEID DRUG REC ACT PT
127886291 12788629 Haematotoxicity

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

no results found